IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TINCANI, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.490
EU - Europa 20.359
AS - Asia 17.638
SA - Sud America 3.774
AF - Africa 591
OC - Oceania 73
Continente sconosciuto - Info sul continente non disponibili 44
Totale 77.969
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.976
CN - Cina 6.255
SG - Singapore 5.444
IT - Italia 4.967
UA - Ucraina 3.998
DE - Germania 3.397
BR - Brasile 3.111
HK - Hong Kong 2.364
PL - Polonia 1.832
FR - Francia 1.257
VN - Vietnam 1.239
FI - Finlandia 1.167
RU - Federazione Russa 1.021
GB - Regno Unito 979
TR - Turchia 714
IE - Irlanda 697
IN - India 472
AR - Argentina 262
BD - Bangladesh 238
CA - Canada 234
SE - Svezia 226
NL - Olanda 192
MX - Messico 177
ES - Italia 160
IQ - Iraq 137
ZA - Sudafrica 131
NG - Nigeria 129
ID - Indonesia 116
MA - Marocco 104
EC - Ecuador 102
JP - Giappone 99
CO - Colombia 84
PK - Pakistan 67
AT - Austria 65
AU - Australia 61
SA - Arabia Saudita 55
VE - Venezuela 55
UZ - Uzbekistan 53
PY - Paraguay 45
CL - Cile 44
EG - Egitto 44
BE - Belgio 42
IL - Israele 42
CZ - Repubblica Ceca 41
EU - Europa 41
JO - Giordania 36
KE - Kenya 35
RO - Romania 35
TN - Tunisia 35
CH - Svizzera 34
DZ - Algeria 34
UY - Uruguay 32
LT - Lituania 31
KZ - Kazakistan 27
AL - Albania 26
NP - Nepal 26
EE - Estonia 25
LB - Libano 25
PH - Filippine 25
AE - Emirati Arabi Uniti 23
GR - Grecia 21
IR - Iran 20
KR - Corea 20
PE - Perù 20
TH - Thailandia 20
AZ - Azerbaigian 19
JM - Giamaica 18
DK - Danimarca 17
PT - Portogallo 17
ET - Etiopia 16
HU - Ungheria 16
BO - Bolivia 15
DO - Repubblica Dominicana 15
SN - Senegal 15
SK - Slovacchia (Repubblica Slovacca) 14
TW - Taiwan 14
MU - Mauritius 12
TT - Trinidad e Tobago 12
CR - Costa Rica 11
HN - Honduras 11
MK - Macedonia 11
BG - Bulgaria 10
LY - Libia 9
NO - Norvegia 9
PS - Palestinian Territory 9
RS - Serbia 9
KG - Kirghizistan 8
LU - Lussemburgo 8
LV - Lettonia 8
MY - Malesia 8
PA - Panama 8
BH - Bahrain 7
BY - Bielorussia 7
GE - Georgia 7
KW - Kuwait 7
SV - El Salvador 7
NZ - Nuova Zelanda 6
OM - Oman 6
AM - Armenia 5
BS - Bahamas 5
Totale 77.862
Salva come PNG Salva come JPEG
Città #
Fairfield 4.277
Woodbridge 3.986
Singapore 2.881
Jacksonville 2.810
Houston 2.743
Ashburn 2.734
Hong Kong 2.338
Warsaw 1.806
Ann Arbor 1.736
Seattle 1.640
Cambridge 1.638
Wilmington 1.514
The Dalles 1.417
Beijing 1.239
Princeton 1.213
San Jose 941
Nanjing 932
Chandler 752
New York 671
Dublin 631
Helsinki 624
Istanbul 572
Lauterbourg 552
Los Angeles 516
Milan 492
Ho Chi Minh City 421
Nanchang 353
Buffalo 303
Des Moines 303
São Paulo 288
Moscow 263
Hanoi 260
Shenyang 251
Munich 246
Rome 236
San Diego 234
Changsha 233
Hebei 230
Dallas 212
Brescia 211
Redondo Beach 191
Tianjin 171
Shanghai 162
Jiaxing 148
London 147
San Francisco 141
Lancaster 137
Chicago 136
Jinan 132
Abuja 124
Verona 122
Florence 119
Council Bluffs 113
Nürnberg 102
Rio de Janeiro 102
Santa Clara 102
Hangzhou 100
Orem 93
Kunming 88
Chennai 84
Tokyo 81
Turku 79
Nuremberg 78
Guangzhou 73
Johannesburg 70
Turin 68
Frankfurt am Main 66
Toronto 65
Bologna 64
Belo Horizonte 62
Dearborn 60
Brooklyn 59
Trieste 59
Zhengzhou 59
Baghdad 57
Boardman 57
Porto Alegre 54
Amsterdam 52
Montreal 52
Dhaka 51
Lanzhou 51
Mexico City 51
Mumbai 51
Ningbo 50
Phoenix 50
Brasília 49
Kocaeli 49
Curitiba 48
Haiphong 48
Paris 48
Atlanta 47
Da Nang 47
Dong Ket 47
Poplar 46
Tashkent 46
Manchester 43
Barcelona 42
Bergamo 42
Genoa 42
Brussels 40
Totale 49.416
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.376
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.817
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). 1.459
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 338
Abatacept reduces levels of switched memory B cells, autoantobodies, and immunoglobulins in patients with Rheumatoid Arthritis 311
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 305
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 301
Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients. 295
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. 277
The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation 253
Transverse Myelitis Activation Post-H1N1 Immunization: A Case of Adjuvant Induction? 249
Preface. What's New in Autoimmunity: New Autoantibodies, New Therapies, New Diseases 237
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 232
Long-term outcome of children of rheumatic disease patients 231
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 227
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. 225
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 219
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 216
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 214
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 204
14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome 204
Antirheumatic drugs and reproduction in women and men with chronic arthritis. 204
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 202
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 200
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 194
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 194
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 193
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 192
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 191
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends 191
Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage 190
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 188
Effect of short-term treatment with lercanidipine on circulating endothelial progenitor cells and structural alterations in retinal arterioles 186
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 186
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 186
Failure of intravenous immunoglobulin to prevent congenital heartblock: Findings of a multicenter, prospective, observational study 183
Typing TREX1 Gene In Patients With Systemic Lupus Erythematosus. 183
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 183
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 183
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. 182
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 182
Anti-phospholipid antibodies 181
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 181
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. 178
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 178
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 177
Children born to SLE and APS mothers 175
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 174
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 173
Management of thrombotic and obstetric antiphospholipid syndrome: A systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults 173
A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus 172
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 172
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 171
Effetto del trattamento a breve termine con lercanidipina sulle cellule progenitrici endoteliali circolanti e sulle alterazioni strutturali delle arteriole retiniche 169
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 168
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 167
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 167
25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies. 166
Antiphospholipid antibodies mediate autoimmunity against dying cells. 166
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 166
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 166
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 165
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 163
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 163
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 162
Inflammatory molecules: A target for treatment of systemic autoimmune diseases. 162
New acquirements on an old molecule: type I interferon. 162
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 162
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 160
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 160
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 160
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 159
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 159
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 157
Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a 'systemic disease'. 156
Pregnancy complications of the antiphospholipid syndrome 155
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 155
Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension 155
Autoimmune polyendocrine Syndromes 154
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 153
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 152
Long-term outcome of children born from mothers with autoimmune diseases 152
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 151
RELATIONSHIP BETWEEN MICROVASCULAR T REGULATORY LYMPHOCYTES AND CIRCULATING LYMPHOCYTES 151
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 151
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 150
Forum interdisciplinare per la ricerca delle malattie autoimmuni (FIRMA) study group. Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. 150
Aicardi Goutieres Syndrome: New Insights on a Novel Set of Inborn Errors of Immunity 150
Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7 150
APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking. 149
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 149
Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? 148
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 148
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment 148
V meeting of the European forum on antiphospholipid antibodies. 147
Impact of in utero environment on the offspring of lupus patients 147
Beyond the "syndrome": antiphospholipid antibodies as risk factors. 147
ANTI-BETA2 GLYCOPROTEIN I-DOMAIN 1 AUTOANTIBODIES: COMPARISON BETWEEN TWO METHODS OF DETECTION 147
State of the art: Reproduction and pregnancy in rheumatic diseases. 147
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO) 147
Totale 23.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 348.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 348.099
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.199 0 0 0 0 0 0 0 0 0 949 886 364
2021/20225.224 279 978 159 312 145 300 317 393 289 556 468 1.028
2022/20233.583 701 46 82 180 281 995 41 288 517 54 206 192
2023/20244.334 235 124 327 346 191 637 156 180 1.244 108 90 696
2024/202510.258 141 131 102 1.184 1.088 918 934 405 866 1.148 2.099 1.242
2025/202618.308 1.792 2.881 1.666 3.190 1.738 1.194 2.712 711 1.112 1.312 0 0
Totale 78.831